The use of carbamazepine to expedite the metabolism of a long-acting aripiprazole injection

被引:0
|
作者
Socco, Samantha [1 ]
Jhawar, Archana [1 ]
Riddle, Michael A. [1 ]
机构
[1] Jesse Brown VA Med Ctr, Inpatient Psychiat Unit, 820 S Damen Ave, Chicago, IL 60612 USA
关键词
antiepileptic drugs; antipsychotics; aripiprazole; carbamazepine; drug interaction; enzyme induction; metabolism; pharmacodynamics; pharmacokinetics; psychiatry; INDUCTION; OXCARBAZEPINE; CYP3A4;
D O I
10.1111/jcpt.13563
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objective Long-acting injectable (LAI) antipsychotics are an integral part of mental health treatment. Modifying an LAI regimen poses several challenges because of the extended half-life of the drug. Case summary An acutely psychotic patient with schizoaffective disorder received aripiprazole lauroxil without resolution of symptoms. She was started on a previously successful regimen of oral fluphenazine. Due to continued psychosis, oral carbamazepine was initiated to expedite the LAI's metabolism allowing subsequent doses of fluphenazine to impart activity. What is new and conclusion Potent cytochrome enzyme inducers may help in transitioning patients from LAI antipsychotics to other therapies.
引用
收藏
页码:562 / 566
页数:5
相关论文
共 50 条
  • [21] Use of aripiprazole long-acting injectable release as a stabiliser. About a case
    Izquierdo De La Puente, A.
    del Sol Calderon, P.
    Fernandez Fernandez, R.
    da Silva, M. V.
    Garcia Moreno, M.
    EUROPEAN PSYCHIATRY, 2024, 67 : S435 - S436
  • [22] Long-acting risperidone injection
    Love, RC
    Conley, RJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (17) : 1792 - 1800
  • [23] Long-Acting Injectable Aripiprazole for a Schizophrenic Patient Concomitant With Stimulant Use Disorder
    Chen, Shih-Fen
    Shen, Yu-Chih
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (05) : 508 - 509
  • [24] Clinical Reasoning in the Use of Long-acting Aripiprazole in Psychosis in Bilateral Nephrectomy on Hemodialysis
    Aziz, Karim Abdel
    Alhashmi, Aysha
    Aziz, Omar Bin Abdul
    Jawabri, Khalid
    Ahmed, Hind Mohd
    Alkaabi, Alyazia
    Stip, Emmanuel
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (04) : 679 - 683
  • [25] Long-Acting Injectable Aripiprazole (Abilify Maintena) for Schizophrenia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1415): : 34 - 36
  • [26] Effectiveness in controlling symptoms with long-acting injectable aripiprazole
    Sanchez Blanco, L.
    Juncal Ruiz, M.
    de Santayana Jenaro, G. Pardo
    Landera Rodriguez, R.
    Gomez Revuelta, M.
    Porta Olivares, O.
    Perez Herrera, M.
    Nunez Moral, N. I.
    EUROPEAN PSYCHIATRY, 2017, 41 : S836 - S836
  • [27] Long-acting risperidone injection reduces healthcare resource use
    Hagström, P
    Mehnert, A
    Leal, A
    Gefvert, O
    NORDIC JOURNAL OF PSYCHIATRY, 2003, 57 (02) : 98 - 98
  • [28] Aripiprazole long-acting injection - a mirror image study of its effects on hospitalisation at one year
    Taylor, David M.
    Sparshatt, Anna
    Amin, Fahima
    Osborne, Ian
    Dzahini, Olubanke
    Hughes, Gwenllian
    Fischetti, Catrin
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (12) : 1564 - 1569
  • [29] Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil
    Hard, Marjie L.
    Wehr, Angela
    von Moltke, Lisa
    Du, Yangchun
    Farwick, Sarah
    Walling, David P.
    Sonnenberg, John
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2019, 9
  • [30] INTRAVASCULAR INJECTION OF LONG-ACTING PENICILLIN
    WALSON, PD
    GALLETTA, G
    PEDIATRICS, 1987, 79 (01) : 165 - 165